001package org.hl7.fhir.r4.model.codesystems;
002
003/*
004  Copyright (c) 2011+, HL7, Inc.
005  All rights reserved.
006  
007  Redistribution and use in source and binary forms, with or without modification, 
008  are permitted provided that the following conditions are met:
009  
010   * Redistributions of source code must retain the above copyright notice, this 
011     list of conditions and the following disclaimer.
012   * Redistributions in binary form must reproduce the above copyright notice, 
013     this list of conditions and the following disclaimer in the documentation 
014     and/or other materials provided with the distribution.
015   * Neither the name of HL7 nor the names of its contributors may be used to 
016     endorse or promote products derived from this software without specific 
017     prior written permission.
018  
019  THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" AND 
020  ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED 
021  WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. 
022  IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, 
023  INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 
024  NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR 
025  PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, 
026  WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) 
027  ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE 
028  POSSIBILITY OF SUCH DAMAGE.
029  
030*/
031
032// Generated on Sun, May 6, 2018 17:51-0400 for FHIR v3.4.0
033
034
035import org.hl7.fhir.exceptions.FHIRException;
036
037public enum ResearchStudyPhase {
038
039        /**
040         * Trials without phases (for example, studies of devices or behavioral interventions).
041         */
042        NA, 
043        /**
044         * Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
045         */
046        EARLYPHASE1, 
047        /**
048         * Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
049         */
050        PHASE1, 
051        /**
052         * Trials that are a combination of phases 1 and 2.
053         */
054        PHASE1PHASE2, 
055        /**
056         * Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
057         */
058        PHASE2, 
059        /**
060         * Trials that are a combination of phases 2 and 3.
061         */
062        PHASE2PHASE3, 
063        /**
064         * Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
065         */
066        PHASE3, 
067        /**
068         * Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
069         */
070        PHASE4, 
071        /**
072         * added to help the parsers
073         */
074        NULL;
075        public static ResearchStudyPhase fromCode(String codeString) throws FHIRException {
076            if (codeString == null || "".equals(codeString))
077                return null;
078        if ("n-a".equals(codeString))
079          return NA;
080        if ("early-phase-1".equals(codeString))
081          return EARLYPHASE1;
082        if ("phase-1".equals(codeString))
083          return PHASE1;
084        if ("phase-1-phase-2".equals(codeString))
085          return PHASE1PHASE2;
086        if ("phase-2".equals(codeString))
087          return PHASE2;
088        if ("phase-2-phase-3".equals(codeString))
089          return PHASE2PHASE3;
090        if ("phase-3".equals(codeString))
091          return PHASE3;
092        if ("phase-4".equals(codeString))
093          return PHASE4;
094        throw new FHIRException("Unknown ResearchStudyPhase code '"+codeString+"'");
095        }
096        public String toCode() {
097          switch (this) {
098            case NA: return "n-a";
099            case EARLYPHASE1: return "early-phase-1";
100            case PHASE1: return "phase-1";
101            case PHASE1PHASE2: return "phase-1-phase-2";
102            case PHASE2: return "phase-2";
103            case PHASE2PHASE3: return "phase-2-phase-3";
104            case PHASE3: return "phase-3";
105            case PHASE4: return "phase-4";
106            default: return "?";
107          }
108        }
109        public String getSystem() {
110          return "http://hl7.org/fhir/research-study-phase";
111        }
112        public String getDefinition() {
113          switch (this) {
114            case NA: return "Trials without phases (for example, studies of devices or behavioral interventions).";
115            case EARLYPHASE1: return "Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.";
116            case PHASE1: return "Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.";
117            case PHASE1PHASE2: return "Trials that are a combination of phases 1 and 2.";
118            case PHASE2: return "Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.";
119            case PHASE2PHASE3: return "Trials that are a combination of phases 2 and 3.";
120            case PHASE3: return "Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.";
121            case PHASE4: return "Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.";
122            default: return "?";
123          }
124        }
125        public String getDisplay() {
126          switch (this) {
127            case NA: return "N/A";
128            case EARLYPHASE1: return "Early Phase 1";
129            case PHASE1: return "Phase 1";
130            case PHASE1PHASE2: return "Phase 1/Phase 2";
131            case PHASE2: return "Phase 2";
132            case PHASE2PHASE3: return "Phase 2/Phase 3";
133            case PHASE3: return "Phase 3";
134            case PHASE4: return "Phase 4";
135            default: return "?";
136          }
137    }
138
139
140}
141